BioCentury
ARTICLE | Clinical News

Idiotypic cancer vaccine: Began Phase I testing

June 28, 1999 7:00 AM UTC

Biomira Inc. (TSE:BRA; BIOM), Edmonton, Alberta Product: Idiotypic cancer vaccine Business: Cancer Therapeutic category: Immune stimulation Target: Cancer cells Description: Liposome-encapsulated pati...